Medpace
Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
drug and medical device clinical development
Investors

News Release

Printer Friendly Version View printer-friendly version
<< Back
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference

CINCINNATI--(BUSINESS WIRE)--Oct. 24, 2016-- Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced that it will present at the following investor conference in November:

Credit Suisse Healthcare Conference
Location: Scottsdale, AZ
Date: Tuesday, November 8, 2016
Presentation: 9:00 a.m. MST (11:00 a.m. EST)
Speakers: Dr. August Troendle, President & Chief Executive Officer, and Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following the event.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,300 people across 35 countries.

Source: Medpace Holdings, Inc.

Media:
Medpace Holdings, Inc.
Mary Kuramoto, 513-579-9911, ext. 2523
m.kuramoto@medpace.com
or
Investors:
investor@medpace.com